These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses. Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523 [TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658 [TBL] [Abstract][Full Text] [Related]
5. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691 [TBL] [Abstract][Full Text] [Related]
6. Positive imaging of thymoma by 11C-acetate positron emission tomography. Ohtsuka T; Nomori H; Watanabe K; Naruke T; Suemasu K; Kosaka N; Uno K Ann Thorac Surg; 2006 Mar; 81(3):1132-4. PubMed ID: 16488747 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670 [TBL] [Abstract][Full Text] [Related]
8. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085 [TBL] [Abstract][Full Text] [Related]
9. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis. Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. Sung YM; Lee KS; Kim BT; Choi JY; Shim YM; Yi CA J Nucl Med; 2006 Oct; 47(10):1628-34. PubMed ID: 17015898 [TBL] [Abstract][Full Text] [Related]
11. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis. Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors. Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602 [TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867 [TBL] [Abstract][Full Text] [Related]
14. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage? Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Agarwal JP; Prabhash K; Noronha V; Joshi A; Kumar R; Rangarajan V Indian J Cancer; 2016; 53(2):270-273. PubMed ID: 28071625 [TBL] [Abstract][Full Text] [Related]
15. Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors. De Luca S; Fonti R; Palmieri G; Federico P; Del Prete G; Pacelli R; Pace L; De Placido S; Salvatore M; Del Vecchio S Clin Nucl Med; 2013 May; 38(5):354-8. PubMed ID: 23486323 [TBL] [Abstract][Full Text] [Related]
16. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eguchi T; Yoshida K; Hamanaka K; Shiina T; Koizumi T; Kawakami S; Oguchi K; Amano J Eur J Cardiothorac Surg; 2012 May; 41(5):1059-62. PubMed ID: 22219437 [TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors. Tomita M; Ayabe T; Tsuchiya K; Nakamura K Thorac Cardiovasc Surg; 2018 Jun; 66(4):345-349. PubMed ID: 28728209 [TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. Sasaki M; Kuwabara Y; Ichiya Y; Akashi Y; Yoshida T; Nakagawa M; Murayama S; Masuda K J Nucl Med; 1999 Oct; 40(10):1595-601. PubMed ID: 10520697 [TBL] [Abstract][Full Text] [Related]
19. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression. Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679 [TBL] [Abstract][Full Text] [Related]
20. [Histologic subtyping and prognosis of thymoma: a study of 108 cases]. Jiao X; Yin HL; Lu ZF; Zhao YC; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):445-9. PubMed ID: 19035114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]